Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 2/20 | 0.53 |
| ▸ | CCR3 | P51677 | 1/20 | 0.52 |
| ▸ | SIGMAR1 | Q99720 | 7/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.48 |
| ▸ | SLC6A12 | P48065 | 1/20 | 0.48 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.48 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8554134 | 0.99 | BCHE (0.52) | BCHECCR3SIGMAR1OPRK1SLC6A12 | |
| SCHEMBL8553603 | 0.90 | BCHE (0.54) | BCHESIGMAR1OPRK1SLC6A12 | |
| SCHEMBL8550210 | 0.89 | SLC6A12 (0.54) | BCHESIGMAR1OPRK1SLC6A12 | |
| Hydrochloric Acid SCHEMBL8553924 | 0.89 | BCHE (0.53) | BCHESIGMAR1OPRK1SLC6A12 | |
| SCHEMBL8551172 | 0.88 | BCHE (0.52) | BCHESIGMAR1OPRK1 | |
| SCHEMBL8551366 | 0.88 | BCHE (0.52) | BCHESIGMAR1OPRK1TMEM97 | |
| Hydrochloric Acid SCHEMBL8550148 | 0.88 | SLC6A12 (0.53) | BCHESIGMAR1OPRK1SLC6A12 | |
| SCHEMBL8550767 | 0.88 | BCHE (0.52) | BCHEOPRK1 | |
| SCHEMBL8555277 | 0.87 | SIGMAR1 (0.51) | BCHESIGMAR1 | |
| SCHEMBL8551180 | 0.87 | BCHE (0.58) | BCHESIGMAR1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5753679-A | SCIZOPHRENIA | HOFFMANN-LA ROCHE INC. (US) | 1998-05-19 | — | — | US | claimed |
| CN-1084329-C | Benzyl piepridine derivs as pharmaceutical agents | HOFFMANN LA ROCHE (CH) | 2002-05-08 | — | — | CN | disclosed |
| EP-0871613-A1 | BENZYL PIPERIDINE DERIVATIVES AS PHARMACEUTICAL AGENTS | F. HOFFMANN-LA ROCHE AG (CH) | 1998-10-21 | — | — | EP | disclosed |
| CN-1183768-A | Benzyl piepridine derivs as pharmaceutical agents | HOFFMANN LA ROCHE (CH) | 1998-06-03 | — | — | CN | disclosed |
| US-5753679-A | SCIZOPHRENIA | HOFFMANN-LA ROCHE INC. (US) | 1998-05-19 | — | — | US | disclosed |
| WO-1996035666-A1 | BENZYL PIPERIDINE DERIVATIVES AS PHARMACEUTICAL AGENTS | F.HOFFMANN-LA ROCHE AG (CH) | 1996-11-14 | — | — | WO | disclosed |